Latest Market News

Elixinol Wellness maintained steady revenue at $3.5 million in Q1 FY26 while boosting gross margins to 45% and reporting a second consecutive quarter of positive underlying operating cash flow.

Rand Mining delivered its March 2026 quarter exploration update for the East Kundana Joint Venture, highlighting 8,831 metres of diamond drilling focused on the Golden Hind and Startrek deposits. While Golden Hind assay results confirmed ongoing mineralisation with no resource update, Startrek drilling progressed with assays awaited.

Kalamazoo Resources reported a robust cash balance of AUD 8.8 million at quarter end, underpinned by a significant equity raise that offsets ongoing exploration and administrative outflows. The company’s funding runway extends beyond three quarters, positioning it to advance its Ashburton Gold Project drilling activities.

Recce Pharmaceuticals has cleared a critical regulatory hurdle in Indonesia with a successful inspection of its Phase 3 clinical trial site for diabetic foot infections, paving the way for potential approval in 2026 amid a large and growing market.

Australian Silica Quartz Group (ASQ) is set to acquire Australian Kaolin, adding a 47Mt inferred kaolin resource at White Swan and launching a $750,000 placement to fund development. The deal hinges on shareholder approval and an Independent Expert’s fairness opinion.

The L1 Global Long Short Fund (ASX:GLS) faced a challenging March quarter amid the Iran War-driven oil supply shock but maintains strong performance since inception through active portfolio adjustments and thematic focus on copper, gold, and infrastructure.

VHM Limited has secured A$5 million through a fully underwritten placement priced at A$0.26 per share, funding critical early engineering and procurement ahead of a mid-2026 final investment decision for its Goschen Rare Earth and Mineral Sands Project.

Red Sky Energy is raising approximately AUD 4.2 million through a fully underwritten non-renounceable rights issue priced at 0.1 cents per share. The capital will fund participation in Santos-operated wells and support ongoing operations.

Invion Limited is broadening its non-melanoma skin cancer trial to include basal cell carcinoma patients following encouraging safety and efficacy data from squamous cell carcinoma cohorts, targeting the largest skin cancer segment.

Lark Distilling Co. edged up net sales to $4.3 million in Q3 FY26, buoyed by growth in travel retail and B2B channels, while unveiling its new Signature Whisky Range that snagged top design honours.

Sunrise Energy Metals has confirmed strong economics for its Syerston Scandium Project with a US$120 million feasibility study, targeting 60 tonnes per year of scandium oxide and potential expansion to 180 tonnes. The project benefits from US government financing interest and rising global demand amid Chinese export restrictions.

Mineral Resources has priced a US$1.3 billion senior unsecured notes offering to refinance higher-cost debt, reduce annual finance expenses by $48 million, and extend its weighted average debt maturity from 3.1 to 5 years.